Profile
David Matly is currently the Chief Commercial & Business Development Officer at Inhibrx Biosciences, Inc. He previously held positions as Vice President-Global Disease Lead at Novartis Oncology, Inc. and Vice President-Business Development at Chrono Therapeutics, Inc. Prior to his current role, he served as the Chief Commercial Officer at Inhibrx, Inc. from 2021 to 2024.
Mr. Matly holds an MBA from Harvard University and an undergraduate degree from Purdue University.
David Matly active positions
| Companies | Position | Start |
|---|
Former positions of David Matly
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 29/05/2024 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Chrono Therapeutics, Inc.
 Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | Corporate Officer/Principal | - |
Training of David Matly
| Purdue University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chrono Therapeutics, Inc. produces transdermal drug products. It is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers real-time behavioral support. The company was founded by Guy DiPierro in 2004 and is headquartered in Hayward, CA. | Commercial Services |
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- David Matly
